TuHURA Biosciences Statistics
Total Valuation
HURA has a market cap or net worth of $185.35 million. The enterprise value is $190.36 million.
Important Dates
The next estimated earnings date is Saturday, February 15, 2025, before market open.
| Earnings Date | Feb 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HURA has 42.03 million shares outstanding.
| Current Share Class | 42.03M |
| Shares Outstanding | 42.03M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 46.07% |
| Owned by Institutions (%) | 0.03% |
| Float | 17.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.92
| Current Ratio | 4.92 |
| Quick Ratio | 3.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$19.33M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -27.20% |
| 50-Day Moving Average | 4.99 |
| 200-Day Moving Average | 6.18 |
| Relative Strength Index (RSI) | 45.74 |
| Average Volume (20 Days) | 513,737 |
Short Selling Information
The latest short interest is 699,044, so 1.66% of the outstanding shares have been sold short.
| Short Interest | 699,044 |
| Short Previous Month | 391,325 |
| Short % of Shares Out | 1.66% |
| Short % of Float | 3.99% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.61M |
| Pretax Income | n/a |
| Net Income | -19.33M |
| EBITDA | -14.48M |
| EBIT | -14.61M |
| Earnings Per Share (EPS) | -$0.25 |
Full Income StatementBalance Sheet
The company has $19.60 million in cash and $24.61 million in debt, giving a net cash position of -$5.01 million or -$0.12 per share.
| Cash & Cash Equivalents | 19.60M |
| Total Debt | 24.61M |
| Net Cash | -5.01M |
| Net Cash Per Share | -$0.12 |
| Equity (Book Value) | -2.77M |
| Book Value Per Share | -0.04 |
| Working Capital | 21.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.16 million and capital expenditures -$76,153, giving a free cash flow of -$15.24 million.
| Operating Cash Flow | -15.16M |
| Capital Expenditures | -76,153 |
| Free Cash Flow | -15.24M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |